Longshenrongfa Pharmaceutical Industry released its performance for the first three quarters, with a net profit attributable to the parent company of 27.0294 million yuan, an increase of 8.11%
I'm PortAI, I can summarize articles.
Longshenrongfa Pharmaceutical Industry released its Q3 2025 report, with operating revenue for the first three quarters at 647 million yuan, a year-on-year decrease of 16.12%. The net profit attributable to the parent company was 27.0294 million yuan, a year-on-year increase of 8.11%. The net profit after deducting non-recurring gains and losses was 28.7134 million yuan, a year-on-year increase of 31.14%. The basic earnings per share were 0.0891 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments